Cns Pharmaceuticals Inc CNSP

$3.56 -0.36 (-9.07%)

Valuation

Market cap
5,253,000
Revenue TTM
$0
Net income TTM
$-15,850,000
P/E (trailing)
0.00
P/E (forward)
—
Profit margin
0.00%
Debt to equity
0.00

Trading

Volume
600
Avg volume
10,038
Day's range
$3.54 – $3.68
Shares out
1,476,000
Stochastic %K
39%
Beta
3.21
Analysts
—
Price target
$10.00

Price

Company profile

CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, engages in the development of therapies for neurology and oncology diseases in the United States. It develops TPI 287, an investigational chemotherapy agent, which is in Phase II clinical trial for the treatment of glioblastoma, metastatic breast cancer with brain metastases, non-small cell lung cancer, castration-resistant prostate cancer, and neuroblasto...

Show more

CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, engages in the development of therapies for neurology and oncology diseases in the United States. It develops TPI 287, an investigational chemotherapy agent, which is in Phase II clinical trial for the treatment of glioblastoma, metastatic breast cancer with brain metastases, non-small cell lung cancer, castration-resistant prostate cancer, and neuroblastoma; and Berubicin, an investigational anthracycline chemotherapy agent, which is in Phase II clinical trial for the treatment of glioblastoma and brain tumors. The company was incorporated in 2017 and is headquartered in Houston, Texas.

Industry
Biotechnology
Sector
Healthcare
Phone
800 946 9185
Website
https://cnspharma.com
Address
2100 West Loop South, Suite 900, Houston, United States

Latest news

Stocktwits

NetworkNewsWire Nov 20, 8:04 PM
AI Model Could Help Personalize Treatment of Pediatric Brain Tumors $CNSP https://ibn.fm/Z3PsO #biomed #stocks
0 replies
BarryJets Nov 16, 11:17 PM
Click the link below to join Starlight ⬇️ Easily the best small-cap community I’ve found 🔥 It’s completely free to join for now, but access is limited!! Todays recentt runnerss : $CNSP $EGG $GYRO |
0 replies
topstockalerts Nov 16, 11:12 PM
$CNSP not exactly explosive, but very difficult to ignore.
0 replies
ClarityOfPurpose2 Nov 16, 7:48 PM
$CNSP They beat per Q3 share earnings expectations because they did very little residual clinical research. Offset to some degree by higher personnel compensation/consulting expenses. Is that really what investors want to see?🤣
0 replies
ClarityOfPurpose2 Nov 16, 7:39 PM
$CNSP New CEO in place for 9 months now. No in/out licensing or acquisitions during that time. Just doing a lot of talking.
0 replies
ReversalRuler Nov 16, 6:11 PM
If you’ve ever wanted to catch a short squeeze early instead of watching it rip after the fact, this group is built for that. Sharing momentum, setups, and what we’re watching as it develops, not when it’s already gone. Click link and join for Free ⭐ $RPID $FLNA $CNSP $SJT 🐂
1 replies
Dailyfollower Nov 16, 5:44 PM 0 replies
Cns_pharma Nov 16, 2:39 PM
$CNSP Reports Third Quarter 2026 Financial Results and Highlights Progress in Establishing Transformative Therapeutic Pipeline https://cnspharma.com/cns-pharmaceuticals-reports-third-quarter-2026-financial-results-and-highlights-progress-in-establishing-transformative-therapeutic-pipeline/
0 replies